Search

Search Constraints

You searched for: Author/Creator Pappo, Alberto S.

Search Results

1. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Issue 16 (2nd May 2014)

2. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Issue 16 (2nd May 2014)

3. A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies. (September 2020)

4. A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. Issue 7 (3rd July 2017)

5. A prospective, comprehensive registry that integrates the molecular analysis of pediatric and adolescent melanocytic lesions. Issue 20 (6th July 2021)

6. Comparison of 18F‐FDG‐PET‐CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Issue 8 (15th April 2016)

10. Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review. (3rd June 2015)